Richard Rodgers
Vermogen: 5 M $ op 31-05-2026
Vermogen: 5 M $ op 31-05-2026
Mr. Richard J.
Rodgers is an Independent Director at Novavax, Inc., an Independent Director at Opus Genetics, Inc. and an Independent Director at Ardelyx, Inc. He is on the Board of Directors at Novavax, Inc., Opus Genetics, Inc. and Ardelyx, Inc. Mr. Rodgers was previously employed as an Independent Director by Sagimet Biosciences, Inc., an Independent Director by Rexahn Pharmaceuticals, Inc., a CFO, Secretary, Treasurer & Executive VP by Tesaro, Inc., a Chief Financial Officer & Senior Vice President by Abraxis BioScience, Inc., a Chief Accounting Officer, Senior VP & Controller by MGI PHARMA, Inc., a Controller by MedSource Technologies Holdings LLC, a Principal by ADC Telecommunications, Inc., and a Principal by Arthur Andersen LLP.
He received his undergraduate degree from St. Cloud State University and an MBA from The Curtis L.
Carlson School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARDELYX, INC. 0,18% | 16-06-2026 | 439.998 ( 0,18% ) | 3 M $ | 31-05-2026 |
OPUS GENETICS, INC. 0,42% | 20-04-2026 | 343.022 ( 0,42% ) | 1 M $ | 31-05-2026 |
NOVAVAX, INC. 0,03% | 20-06-2026 | 47.370 ( 0,03% ) | 519 649 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARDELYX, INC. | Directeur/Bestuurslid | 01-03-2014 |
| OPUS GENETICS, INC. | Directeur/Bestuurslid | 01-11-2020 |
| NOVAVAX, INC. | Directeur/Bestuurslid | 29-10-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Directeur/Bestuurslid | 05-06-2024 |
| REXAHN PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-11-2020 |
| TESARO INC | Oprichter | 31-08-2013 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Financieel Directeur/CFO | 03-02-2010 |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Comptroller/Controller/Auditor | 01-01-2009 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 13 |
|---|---|
CommScope Connectivity LLC
CommScope Connectivity LLC Telecommunications EquipmentElectronic Technology Provides broadband communications network infrastructure products and related services | Electronic Technology |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Health Technology |
Novavax, Inc.
Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
MedSource Technologies Holdings LLC
MedSource Technologies Holdings LLC Medical SpecialtiesHealth Technology Provides engineering, manufacturing and supply chain management services for the medical device industry | Health Technology |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
St. Cloud State University
St. Cloud State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rexahn Pharmaceuticals, Inc.
Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Sagimet Biosciences, Inc.
Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
The Curtis L. Carlson School of Management
The Curtis L. Carlson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocuphire Pharma, Inc.
Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau